Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 17, Issue 12, Pages 1365-1378
Publisher
Future Medicine Ltd
Online
2016-07-27
DOI
10.2217/pgs-2016-0074
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIF1α Genetic Variants and Protein Expressions Determine the Response to Platinum Based Chemotherapy and Clinical Outcome in Patients with Advanced NSCLC
- (2017) Fenglei Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients
- (2016) Ji-Ye Yin et al. CANCER LETTERS
- Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients
- (2015) Ji-ye Yin et al. ACTA PHARMACOLOGICA SINICA
- ERCC1SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
- (2015) Aristea Kalikaki et al. CANCER INVESTIGATION
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
- (2015) Heng Xu et al. NATURE GENETICS
- The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients
- (2015) Tomasz Kucharczyk et al. PATHOLOGY & ONCOLOGY RESEARCH
- Association between polymorphisms of BAG-1 and XPD and chemotherapy sensitivity in advanced non-small-cell lung cancer patients treated with vinorelbine combined cisplatin regimen
- (2015) Ping Li et al. TUMOR BIOLOGY
- Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy
- (2015) Yu Peng et al. Scientific Reports
- Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
- (2014) Ivana Sullivan et al. CANCER LETTERS
- Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer
- (2014) D. Liu et al. GENETICS AND MOLECULAR RESEARCH
- Association of xeroderma pigmentosum group D (Asp312Asn, Lys751Gln) and cytidine deaminase (Lys27Gln, Ala70Thr) polymorphisms with outcome in Chinese non-small cell lung cancer patients treated with cisplatin-gemcitabine
- (2014) M. Zhou et al. GENETICS AND MOLECULAR RESEARCH
- Polymorphisms in the XRCC1 gene are associated with treatment response to platinum chemotherapy in advanced non-small cell lung cancer patients based on meta-analysis
- (2014) L. Li et al. GENETICS AND MOLECULAR RESEARCH
- Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer
- (2014) Z.Y. Jin et al. GENETICS AND MOLECULAR RESEARCH
- Pharmacogenetics of DNA repair gene polymorphisms in non-small-cell lung carcinoma patients on platinum-based chemotherapy
- (2014) L. Zhang et al. GENETICS AND MOLECULAR RESEARCH
- Association of DNA base excision repair genes (OGG1,APE1andXRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients
- (2014) Yu Peng et al. INTERNATIONAL JOURNAL OF CANCER
- Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
- (2014) Paweł Krawczyk et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer
- (2014) You-Hua Jiang et al. MEDICAL ONCOLOGY
- Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer
- (2014) Hongying Lv et al. MEDICAL ONCOLOGY
- The Association of Transporter Genes Polymorphisms and Lung Cancer Chemotherapy Response
- (2014) Ying Wang et al. PLoS One
- The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis
- (2014) Yanlong Yang et al. TUMOR BIOLOGY
- The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients
- (2014) Xiang-Ping Li et al. TUMOR BIOLOGY
- Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients
- (2014) Xin Zhao et al. TUMOR BIOLOGY
- Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
- (2014) Xiaoying Li et al. TUMOR BIOLOGY
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer
- (2013) Hong-mei Fang et al. ACTA PHARMACOLOGICA SINICA
- Common Variations of DNA Repair Genes are Associated with Response to Platinum-based Chemotherapy in NSCLCs
- (2013) Xian-Dong Li et al. Asian Pacific Journal of Cancer Prevention
- XPG is Predictive Gene of Clinical Outcome in Advanced Non-small-cell Lung Cancer with Platinum Drug Therapy
- (2013) Tian Zhang et al. Asian Pacific Journal of Cancer Prevention
- ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
- (2013) M Tiseo et al. BRITISH JOURNAL OF CANCER
- Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer
- (2013) Wan Zhao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a
- (2013) Ji-Ye Yin et al. CARCINOGENESIS
- Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: A pooled analysis based on 39 reports
- (2013) Tong-Peng Xu et al. GENE
- Two Novel Functional Single Nucleotide Polymorphisms ofADRB3Are Associated With Type 2 Diabetes in the Chinese Population
- (2013) Qiong Huang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population
- (2013) Wei Hong et al. Journal of Zhejiang University-SCIENCE B
- Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer
- (2013) Francesca Mazzoni et al. LUNG CANCER
- Current approaches forTYMSpolymorphisms and their importance in molecular epidemiology and pharmacogenetics
- (2013) Aurea Lima et al. PHARMACOGENOMICS
- Predictive Value of XPD Polymorphisms on Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2013) Mantang Qiu et al. PLoS One
- XRCC3 Thr241Met Polymorphism and Clinical Outcomes of NSCLC Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis
- (2013) Xiao-yong Shen et al. PLoS One
- Polymorphisms in XPD Gene Could Predict Clinical Outcome of Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer Patients: A Meta-Analysis of 24 Studies
- (2013) Qin Qin et al. PLoS One
- XRCC3 Thr241Met Is Associated with Response to Platinum-Based Chemotherapy but Not Survival in Advanced Non-Small Cell Lung Cancer
- (2013) Mantang Qiu et al. PLoS One
- Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer
- (2013) Shao-jun Huang et al. TUMOR BIOLOGY
- The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
- (2013) Yanlong Yang et al. TUMOR BIOLOGY
- Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis
- (2013) Ning Zhu et al. YONSEI MEDICAL JOURNAL
- Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer
- (2012) Caiyun He et al. ANTI-CANCER DRUGS
- Genetic Variants of NBS1 Predict Clinical Outcome of Platinum-based Chemotherapy in Advanced Non-small Cell Lung Cancer in Chinese
- (2012) Jia-Li Xu et al. Asian Pacific Journal of Cancer Prevention
- Association betweeneIF3αpolymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients
- (2012) Xiaojing Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer
- (2012) M. Provencio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Association ofCASP3polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy
- (2012) Shaohua Gu et al. CANCER SCIENCE
- Association of CASP7 Polymorphisms and Survival of Patients With Non-small Cell Lung Cancer With Platinum-Based Chemotherapy Treatment
- (2012) Ji Qian et al. CHEST
- Predictive Value of XRCC1 Gene Polymorphisms on Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients: A Systematic Review and Meta-analysis
- (2012) J. Wu et al. CLINICAL CANCER RESEARCH
- Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer — a pilot study
- (2012) Paweł Krawczyk et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum
- (2012) Wei-Yu Liao et al. Journal of Thoracic Oncology
- XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies
- (2012) Jian Chen et al. Journal of Zhejiang University-SCIENCE B
- Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
- (2012) Xiaojing Xu et al. LUNG CANCER
- Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy
- (2012) Seok-Hyun Kim et al. LUNG CANCER
- The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients
- (2012) Xiaojing Xu et al. LUNG CANCER
- Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer
- (2012) Li Liu et al. MOLECULAR CARCINOGENESIS
- Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
- (2012) Wenting Wu et al. PLoS One
- Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients
- (2012) Ji-Ye Yin et al. PLoS One
- Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients
- (2012) Dianke Yu et al. TUMOR BIOLOGY
- Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC
- (2012) Fenglei Wu et al. CELLULAR ONCOLOGY
- Lack of correlation between ERCC1 (C8092A) Single Nucleotide Polymorphism and efficacy/toxicity of platinum based chemotherapy in Chinese patients with advanced Non-Small Cell Lung Cancer
- (2011) V KimCurran et al. Advances in Medical Sciences
- Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy
- (2011) Xueying Zhao et al. CANCER
- Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy
- (2011) Markus Joerger et al. CANCER
- Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
- (2011) Giulio Metro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
- (2011) J.-Y. Yin et al. CLINICAL CANCER RESEARCH
- Thymidylate Synthase Genotype-Directed Neoadjuvant Chemoradiation for Patients With Rectal Adenocarcinoma
- (2011) Benjamin R. Tan et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Cytidine Deaminase and Xeroderma Pigmentosum Group D Polymorphisms with Response, Toxicity, and Survival in Cisplatin/Gemcitabine-Treated Advanced Non-small Cell Lung Cancer Patients
- (2011) Vienna Ludovini et al. Journal of Thoracic Oncology
- Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer Patients
- (2011) WeiYing Li et al. LUNG
- DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy
- (2011) Dairong Li et al. MEDICAL ONCOLOGY
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of polymorphisms inMTHFR677 C→T,TYMS3R→2R andMTR2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC
- (2011) Lian-Hua Cui et al. PHARMACOGENOMICS
- Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
- (2011) H E Wheeler et al. PHARMACOGENOMICS JOURNAL
- RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis
- (2011) Natsuko Suwaki et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Polymorphisms in hMSH2 and hMLH1 and response to platinum-based chemotherapy in advanced non-small-cell lung cancer patients
- (2010) H. Cheng et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Association Between Polymorphisms of ERCC1 and XPD and Clinical Response to Platinum-Based Chemotherapy in Advanced Non–Small Cell Lung Cancer
- (2010) Fan Li et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments
- (2010) Ji‑Ye Yin et al. BIOSCIENCE REPORTS
- Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients
- (2010) Songjian Chen et al. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
- Predictive Effects of ERCC1 and XRCC3 SNP on Efficacy of Platinum-based Chemotherapy in Advanced NSCLC Patients
- (2010) C. Zhou et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non–Small-Cell Lung Cancer
- (2010) Kouya Shiraishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine
- (2010) N. Viñolas et al. LUNG CANCER
- No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis
- (2010) Ming Yin et al. LUNG CANCER
- Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients
- (2010) Baohui Han et al. LUNG CANCER
- Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis
- (2010) Shu-zhen Wei et al. MEDICAL ONCOLOGY
- CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients
- (2010) A. ADA et al. NEOPLASMA
- XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer
- (2009) J. Feng et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
- (2009) Ning Sun et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non–Small-Cell Lung Cancer
- (2009) Aristea Kalikaki et al. Clinical Lung Cancer
- Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer
- (2009) Egbert F. Smit et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
- (2009) Xinchen Sun et al. LUNG CANCER
- Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients
- (2009) Tomoyoshi Takenaka et al. LUNG CANCER
- Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population
- (2009) Ji-Ye Yin et al. Pharmacogenetics and Genomics
- Polymorphisms inABCG2,ABCC3andCNT1genes and their possible impact on chemotherapy outcome of lung cancer patients
- (2008) Phillip J. Müller et al. INTERNATIONAL JOURNAL OF CANCER
- A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
- (2008) Thorgeir E. Thorgeirsson et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started